Strona 4 - Najlepsi lekarze do leczenia raka szyjki macicy – TOP 123 lekarzy

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Profesor Kyzas specjalizuje się w onkologii chirurgicznej głowy i szyi. Skupia się na mikrochirurgicznym przenoszeniu wolnych płatów tkankowych oraz spersonalizowanym planowaniu 3D w chirurgii rekonstrukcyjnej.

• Przeszedł szkolenie w zakresie chirurgii stomatologicznej i szczękowo-twarzowej w czołowych brytyjskich szpitalach klinicznych
• Jest głównym badaczem w międzynarodowych badaniach nad przezustną resekcją laserową
• Został wyróżniony prestiżową krajową nagrodą National Clinical Excellence Award (Bronze)
• Pełni funkcję redaktora naczelnego British Journal of Oral and Maxillofacial Surgery
• Jest dyrektorem klinicznym usług onkologicznych obejmujących opieką ponad milion osób

Specjalizuje się w onkologii klinicznej i odbył rozległe szkolenie na Uniwersytecie Akdeniz. Dr Alemdar koncentruje się na leczeniu raka szyjki macicy w Medical Park Antalya.

• Posiada certyfikat specjalisty onkologii klinicznej od 2018 roku
• Ponad 15 lat doświadczenia w onkologii
• Pracował w Szpitalu Uniwersyteckim Akdeniz — wiodącym ośrodku onkologicznym

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr Ercan Ozden specjalizuje się w leczeniu raka szyjki macicy. Posiada ponad 20-letnie doświadczenie medyczne, a wykształcenie zdobył na prestiżowym Wydziale Medycznym Cerrahpaşa Uniwersytetu Stambulskiego.

• Ukończył podspecjalizację z onkologii klinicznej na Uniwersytecie Kocaeli, przechodząc specjalistyczne szkolenie w zakresie leczenia nowotworów.
• Posiada bogate doświadczenie zdobyte w wielu szpitalach, gdzie zajmował się różnorodnymi przypadkami onkologicznymi.
• Jest absolwentem anglojęzycznych studiów medycznych na wydziale Cerrahpaşa.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Hisham Khalifa is a Consultant Surgical Oncologist. He assesses, diagnoses, and operates on gynecological cancers, including ovarian, uterine, cervical, vaginal, and vulval cancers. He performs both minimally invasive (laparoscopic) and open surgery.

Career milestones: Resident and faculty member at the National Cancer Institute, Cairo University (2001–2014). Assistant Professor at AlFaisal University and Assistant Consultant at King Faisal Hospital and Research Center (KFSHRC), Riyadh (2014–2019). Consultant at the NCI, Cairo (2019–present); Director of the Professional Diploma in Gyne-Onco Surgery. Consultant at the Oncology Pediatric Hospital–Alexandria University and Shefa Al Orman Comprehensive Cancer Center, Luxor (2020–present).

Credentials: MBBCh (1999); Master’s in General Surgery (2004); Doctorate in Surgical Oncology (2008); Fellowship of the European Board of Surgery (FEBS, UEMS). Memberships: FACS; SSO; ESSO; ECS; EGSSO.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Lekarz Kierujący Oddziałem Położnictwa i Ginekologii w Szpitalu Asklepios Barmbek.

• Specjalizuje się w leczeniu raka szyjki macicy
• Kieruje wyspecjalizowanym zespołem w dziedzinie położnictwa i ginekologii
• Koncentruje się na opiece zorientowanej na potrzebach pacjenta

Specjalistka w zakresie małoinwazyjnej chirurgii raka szyjki macicy — dr Stergiou-Tsaroucha koncentruje się na zachowaniu zdrowia reprodukcyjnego podczas leczenia schorzeń narządów miednicy mniejszej.

• Ekspert w dziedzinie zabiegów histerektomii
• Leczy choroby jajników oraz wypadanie narządów miednicy mniejszej
• Pracuje w szpitalu Asklepios Barmbek

Dr Kim Tae Joong jest oddanym ginekologiem i onkologiem ginekologicznym w Samsung Medical Center.

• Specjalizuje się w onkologii ginekologicznej
• Pracuje w wiodącym centrum medycznym w Korei Południowej
• Koncentruje się na leczeniu raka szyjki macicy

Specjalizuje się w ginekologii onkologicznej w Samsung Medical Center — koncentruje się wyłącznie na przypadkach raka szyjki macicy.

• Posiada ekspercką wiedzę w zakresie nowoczesnych metod leczenia raka szyjki macicy
• Pracuje w czołowym centrum medycznym w Korei Południowej
• Zapewnia spersonalizowaną opiekę nad pacjentem

Główny badacz w badaniach klinicznych nad rakiem szyjki macicy — dr Oaknin kieruje badaniami nad angiogenezą i naprawą DNA w Hospital Quiron Barcelona.

• Jest autorką ponad 100 publikacji na temat nowotworów ginekologicznych
• Reprezentuje Hiszpanię w Komitecie ds. Raka Szyjki Macicy GCIG
• Jest wykładowcą w ramach programu Gyn-Track w ESMO
• Specjalizowała się w onkologii klinicznej w Hospital Universitario de la Princesa

Czołowy onkolog ginekologiczny, specjalizujący się w operacjach endoskopowych i laparoskopowych w zakresie onkologii ginekologicznej w Herzliya Medical Center.

• Leczy choroby macicy, szyjki macicy i jajników
• Kieruje Oddziałem Położnictwa i Ginekologii w Centrum Medycznym Meir
• Specjalizuje się w małoinwazyjnych technikach chirurgicznych